Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Environmental and Molecular Mutagenesis
|
October 28, 2017
A regenerative erythropoietic response does not increase the frequency of Pig-a mutant reticulocytes and erythrocytes in Sprague-Dawley rats
John Nicolette, Joel Murray, Paul Sonders, et al.
Environmental and Molecular Mutagenesis
|
February 4, 2016
Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test
John Nicolette, Robin E Neft, Jessica Vanosdol, et al.
Environmental and Molecular Mutagenesis
|
October 22, 2010
In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells
John Nicolette, Marilyn Diehl, Paul Sonders, et al.
Environmental and Molecular Mutagenesis
|
September 20, 2020
In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine
John Nicolette, Joel Murray, Paul Sonders, et al.
International Journal of Toxicology
|
February 2, 2021
Deriving Compound-Specific Exposure Limits for Chemicals Used in Pharmaceutical Synthesis: Challenges in Expert Decision-Making Exemplified Through a Case Study-Based Workshop
William C Drewe, Krista L Dobo, Zhanna Sobol, et al.
Mutagenesis
|
December 18, 2010
Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future
Svetlana Avlasevich, Steven Bryce, Marlies De Boeck, et al.
Environmental and Molecular Mutagenesis
|
December 2, 2009
High content flow cytometric micronucleus scoring method is applicable to attachment cell lines
Steven M Bryce, Jing Shi, John Nicolette, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates
Catrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Environmental and Molecular Mutagenesis
|
November 14, 2021
Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide
John Nicolette, Mirjam Luijten, Jennifer C Sasaki, et al.
Environmental and Molecular Mutagenesis
|
June 5, 2021
Permitted daily exposure limits for noteworthy N-nitrosamines
George E Johnson, Krista Dobo, Bhaskar Gollapudi, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Environmental and Molecular Mutagenesis
|
October 28, 2017
A regenerative erythropoietic response does not increase the frequency of Pig-a mutant reticulocytes and erythrocytes in Sprague-Dawley rats
John Nicolette, Joel Murray, Paul Sonders, et al.
Environmental and Molecular Mutagenesis
|
February 4, 2016
Peptide bond-forming reagents HOAt and HATU are not mutagenic in the bacterial reverse mutation test
John Nicolette, Robin E Neft, Jessica Vanosdol, et al.
Environmental and Molecular Mutagenesis
|
October 22, 2010
In vitro micronucleus screening of pharmaceutical candidates by flow cytometry in Chinese hamster V79 cells
John Nicolette, Marilyn Diehl, Paul Sonders, et al.
Environmental and Molecular Mutagenesis
|
September 20, 2020
In vitro and in vivo mammalian mutation assays support a nonmutagenic mechanism of carcinogenicity for hydrazine
John Nicolette, Joel Murray, Paul Sonders, et al.
International Journal of Toxicology
|
February 2, 2021
Deriving Compound-Specific Exposure Limits for Chemicals Used in Pharmaceutical Synthesis: Challenges in Expert Decision-Making Exemplified Through a Case Study-Based Workshop
William C Drewe, Krista L Dobo, Zhanna Sobol, et al.
Mutagenesis
|
December 18, 2010
Flow cytometric analysis of micronuclei in mammalian cell cultures: past, present and future
Svetlana Avlasevich, Steven Bryce, Marlies De Boeck, et al.
Environmental and Molecular Mutagenesis
|
December 2, 2009
High content flow cytometric micronucleus scoring method is applicable to attachment cell lines
Steven M Bryce, Jing Shi, John Nicolette, et al.
Regulatory Toxicology and Pharmacology : RTP
|
October 15, 2020
Management of pharmaceutical ICH M7 (Q)SAR predictions - The impact of model updates
Catrin Hasselgren, Joel Bercu, Alex Cayley, et al.
Environmental and Molecular Mutagenesis
|
November 14, 2021
Utility of a next-generation framework for assessment of genomic damage: A case study using the pharmaceutical drug candidate etoposide
John Nicolette, Mirjam Luijten, Jennifer C Sasaki, et al.
Environmental and Molecular Mutagenesis
|
June 5, 2021
Permitted daily exposure limits for noteworthy N-nitrosamines
George E Johnson, Krista Dobo, Bhaskar Gollapudi, et al.
Page
of 2